Workflow
翔宇医疗收盘上涨2.81%,滚动市盈率122.02倍,总市值105.94亿元

Group 1 - The core business of the company is the research, production, and sales of rehabilitation medical devices, with a wide range of products across 10 categories and over 1,000 types [2] - The company achieved a revenue of 186 million yuan in Q1 2025, representing a year-on-year increase of 10.02%, while net profit decreased by 41.26% to 22.95 million yuan [3] - The company's rolling price-to-earnings (PE) ratio reached 122.02, marking a new low in 965 days, with a total market capitalization of 10.594 billion yuan [1] Group 2 - The average PE ratio for the medical device industry is 57.48, with a median of 40.95, placing the company at 107th in industry rankings [1] - The company has received multiple awards for its projects, including first prizes from the Chinese Rehabilitation Medicine Association and various provincial awards for technological advancements in rehabilitation [2] - As of March 31, 2025, the number of shareholders increased to 5,895, with an average holding value of 352,800 yuan per shareholder [1]